Also, the 14 genes common to NAFL-NASH and NASH patients were involved in PI3K/AKT/mTOR, inflammatory, ECMR and oncogenic pathways (Supplementary Fig. S6) suggesting a progression from NAFL to NASH. This evidence concerns the gene MTOR and non-alcoholic fatty liver.